1. Pink Sheet

UK MHRA Aims To Cast Early Access Scheme In New Light

Agency Wants To Make EAMS More Attractive To Sponsors Of Innovative Medicines

 
• By Vibha Sharma

The UK’s Early Access to Medicines Scheme continues to provide important flexibility, but companies also now have the option of a new ambitious pathway launched this year for accelerating time to market for innovative medicines.

A group of paper airplanes, one plane is flying in the other direction
EAMS allows promising drugs to be used in clinical practice in parallel with the later stages of the regulatory process • Source: Alamy

The UK Medicines and Healthcare products Regulatory Agency is looking to raise the profile of its Early Access to Medicines Scheme (EAMS), which allows patients with life threatening or seriously debilitating conditions to get faster access to promising but unlicensed drugs.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe